Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients

The present study evaluated the effectiveness of micronized palmitoylethanolamide (PEA-m) treatment in reducing the painful symptoms experienced by diabetic patients with peripheral neuropathy. PEA-m, a fatty acid amide of the N-acylethanolamine family, was administered (300 mg twice daily) to 30 di...

Descripción completa

Detalles Bibliográficos
Autores principales: Schifilliti, Chiara, Cucinotta, Lelio, Fedele, Viviana, Ingegnosi, Carmela, Luca, Salvatore, Leotta, Carmelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996286/
https://www.ncbi.nlm.nih.gov/pubmed/24804094
http://dx.doi.org/10.1155/2014/849623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996286/
https://www.ncbi.nlm.nih.gov/pubmed/24804094
http://dx.doi.org/10.1155/2014/849623

Ejemplares similares